Selenium-binding protein 1: its physiological function, dependence on aryl hydrocarbon receptors, and role in wasting syndrome by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
暂无分享,去创建一个
Satoshi O. Suzuki | H. Uchi | M. Furue | Y. Ishii | H. Yamada | Midori Yamamoto | T. Takeda | M. Himeno | S. Takechi | K. Tsukimori | T. Ishida | Tadatoshi Yamaguchi | S. Tsujimoto | Yuko Onomura
[1] T. Kondo,et al. Decreased Selenium-Binding Protein 1 Enhances Glutathione Peroxidase 1 Activity and Downregulates HIF-1α to Promote Hepatocellular Carcinoma Invasiveness , 2012, Clinical Cancer Research.
[2] W. Dong,et al. Reduced selenium-binding protein 1 is associated with poor survival rate in gastric carcinoma , 2011, Medical oncology.
[3] S. Costantini,et al. Structural and functional studies of the human selenium binding protein-1 and its involvement in hepatocellular carcinoma. , 2011, Biochimica et biophysica acta.
[4] L. D. White,et al. Molecular and Functional Characteristics of Ovarian Surface Epithelial Cells Transformed by KrasG12D and loss of Pten in a Mouse Model in vivo , 2011, Oncogene.
[5] Liying Wu,et al. Notch1 expression correlates with tumor differentiation status in ovarian carcinoma , 2010, Medical oncology.
[6] Wancai Yang,et al. Functional and physical interaction between the selenium-binding protein 1 (SBP1) and the glutathione peroxidase 1 selenoprotein. , 2010, Carcinogenesis.
[7] H. Wariishi,et al. Maternal exposure to dioxin reduces hypothalamic but not pituitary metabolome in fetal rats: a possible mechanism for a fetus-specific reduction in steroidogenesis. , 2010, The Journal of toxicological sciences.
[8] D. Beer,et al. Decreased Selenium-Binding Protein 1 in Esophageal Adenocarcinoma Results from Posttranscriptional and Epigenetic Regulation and Affects Chemosensitivity , 2010, Clinical Cancer Research.
[9] C. Sung,et al. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma. , 2010, Human pathology.
[10] Y. Fujii‐Kuriyama,et al. Molecular mechanisms of the physiological functions of the aryl hydrocarbon (dioxin) receptor, a multifunctional regulator that senses and responds to environmental stimuli , 2010, Proceedings of the Japan Academy. Series B, Physical and biological sciences.
[11] Wancai Yang,et al. Transcriptional Regulation and Biological Functions of Selenium-Binding Protein 1 in Colorectal Cancer In Vitro and in Nude Mouse Xenografts , 2009, PloS one.
[12] Huirong Shi,et al. [Expression and significance of P53, P21WAF1 and CDK1 proteins in epithelial ovarian cancer]. , 2009, Ai zheng = Aizheng = Chinese journal of cancer.
[13] A. Sytkowski,et al. Human selenium binding protein-1 (hSP56) interacts with VDU1 in a selenium-dependent manner. , 2009, Biochemical and biophysical research communications.
[14] A. Raval,et al. Proteome profiling of aging in mouse models: Differential expression of proteins involved in metabolism, transport, and stress response in kidney , 2009, Proteomics.
[15] D. Arango,et al. Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. , 2008, Molecular nutrition & food research.
[16] B. Rosen,et al. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings. , 2007, Oncology reports.
[17] Kathleen R. Cho,et al. Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways. , 2007, Cancer cell.
[18] John A Thompson,et al. Mechanistic basis for inflammation and tumor promotion in lungs of 2,6-di-tert-butyl-4-methylphenol-treated mice: electrophilic metabolites alkylate and inactivate antioxidant enzymes. , 2007, Chemical research in toxicology.
[19] Brock Chittim,et al. Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[20] Hoguen Kim,et al. Suppression of human selenium‐binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival , 2006, Proteomics.
[21] R. Berkowitz,et al. Selenium binding protein 1 in ovarian cancer , 2006, International journal of cancer.
[22] L. D. White,et al. Dominant-stable beta-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model. , 2006, Cancer research.
[23] Jacques Corbeil,et al. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[24] H. Hellmold,et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study. , 2005, Toxicology and applied pharmacology.
[25] A. Akamine,et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced change in intestinal function and pathology: evidence for the involvement of arylhydrocarbon receptor-mediated alteration of glucose transportation. , 2005, Toxicology and applied pharmacology.
[26] M. Salemi,et al. Characterization of a structurally intact in situ lung model and comparison of naphthalene protein adducts generated in this model vs lung microsomes. , 2005, Chemical research in toxicology.
[27] Y. Ishii,et al. Effects of dioxins on stress-responsive systems and their relevance to toxicity , 2005 .
[28] Hong Liu,et al. Protein Profiling of Mouse Livers with Peroxisome Proliferator-Activated Receptor α Activation , 2004, Molecular and Cellular Biology.
[29] Allan B. Okey,et al. Role of Aryl Hydrocarbon Receptor-mediated Induction of the CYP1 Enzymes in Environmental Toxicity and Cancer* , 2004, Journal of Biological Chemistry.
[30] K. Miyaguchi. Localization of selenium-binding protein at the tips of rapidly extending protrusions , 2004, Histochemistry and Cell Biology.
[31] David E. Misek,et al. Reduced selenium‐binding protein 1 expression is associated with poor outcome in lung adenocarcinomas , 2004, The Journal of pathology.
[32] A. Kyriakopoulos,et al. Mammalian selenium-containing proteins. , 2003, Annual review of nutrition.
[33] S. Bae,et al. Differential expression of the liver proteome in senescence accelerated mice , 2003, Proteomics.
[34] P. Carlsson,et al. Wnt-signalling pathway in ovarian epithelial tumours: increased expression of β-catenin and GSK3β , 2003, British Journal of Cancer.
[35] A. Flesken-Nikitin,et al. Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. , 2003, Cancer research.
[36] H. Burger,et al. FSH-regulated gene expression profiles in ovarian tumours and normal ovaries. , 2002, Molecular human reproduction.
[37] K. Burns,et al. Inhibin and p27 interact to regulate gonadal tumorigenesis. , 2001, Molecular endocrinology.
[38] D. Lubman,et al. Mouse liver selenium‐binding protein decreased in abundance by peroxisome proliferators , 2000, Electrophoresis.
[39] A. Porat,et al. A 56-kDa Selenium-binding Protein Participates in Intra-Golgi Protein Transport* , 2000, The Journal of Biological Chemistry.
[40] K. Hasegawa,et al. Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR , 2000, British Journal of Cancer.
[41] Y. Bignon,et al. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review). , 2000, International journal of oncology.
[42] Y. Ishii,et al. Induction of a cytosolic 54 kDa protein in rat liver that is highly homologous to selenium-binding protein. , 1998, Environmental toxicology and pharmacology.
[43] A. Burlingame,et al. Identification of the Hepatic Protein Targets of Reactive Metabolites of Acetaminophen in Vivo in Mice Using Two-dimensional Gel Electrophoresis and Mass Spectrometry* , 1998, The Journal of Biological Chemistry.
[44] M. Bansal,et al. Redox modulation of selenium binding proteins by cadmium exposures in mice , 1997, Molecular and Cellular Biochemistry.
[45] H. Yamada,et al. Changes in the hepatic glutathione peroxidase redox system produced by coplanar polychlorinated biphenyls in Ah-responsive and -less-responsive strains of mice: mechanism and implications for toxicity. , 1997, Environmental toxicology and pharmacology.
[46] G. Yost,et al. Production and characterization of specific antibodies: utilization to predict organ- and species-selective pneumotoxicity of 3-methylindole. , 1997, Toxicology and applied pharmacology.
[47] Y. Ishii,et al. Significant induction of a 54-kDa protein in rat liver with homologous alignment to mouse selenium binding protein by a coplanar polychlorinated biphenyl, 3,4,5,3',4'-pentachlorobiphenyl and 3-methylcholanthrene. , 1996, Toxicology letters.
[48] T. Stadtman,et al. A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[49] J. Manautou,et al. Evidence for common binding of acetaminophen and bromobenzene to the 58-kDa acetaminophen-binding protein. , 1995, Journal of toxicology and environmental health.
[50] L. Moroder,et al. Redox potentials of active-site bis(cysteinyl) fragments of thiol-protein oxidoreductases. , 1993, Biochemistry.
[51] P. Harrison,et al. Different patterns of regulation of the genes encoding the closely related 56 kDa selenium- and acetaminophen-binding proteins in normal tissues and during carcinogenesis. , 1993, Carcinogenesis.
[52] B. Martin,et al. A metabolite of acetaminophen covalently binds to the 56 kDa selenium binding protein. , 1992, Biochemical and biophysical research communications.
[53] R. Cook,et al. DNA sequencing of a mouse liver protein that binds selenium: implications for selenium's mechanism of action in cancer prevention. , 1990, Carcinogenesis.
[54] F. Kittrell,et al. Distribution of selenium-binding proteins in different tissues of the mouse and rat. , 1989, In vivo.
[55] D. Medina,et al. Evidence for two selenium-binding proteins distinct from glutathione peroxidase in mouse liver. , 1989, Carcinogenesis.
[56] R. Birge,et al. Immunochemical analysis of acetaminophen covalent binding to proteins. Partial characterization of the major acetaminophen-binding liver proteins. , 1988, Biochemical pharmacology.
[57] P. Harrison,et al. The structure of the mouse glutathione peroxidase gene: the selenocysteine in the active site is encoded by the ‘termination’ codon, TGA. , 1986, The EMBO journal.
[58] S. Stohs,et al. Effects of BHA, d-alpha-tocopherol and retinol acetate on TCDD-mediated changes in lipid peroxidation, glutathione peroxidase activity and survival. , 1984, Xenobiotica; the fate of foreign compounds in biological systems.
[59] S. Stohs,et al. Lipid peroxidation as a possible cause of TCDD toxicity. , 1983, Biochemical and biophysical research communications.
[60] K. Yagi,et al. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. , 1979, Analytical biochemistry.
[61] Sugiura Mamoru,et al. A simple colorimetric method for determination of serum triglycerides with lipoprotein lipase and glycerol dehydrogenase. , 1977, Clinica chimica acta; international journal of clinical chemistry.
[62] R. A. Lutz,et al. Kinetic determination of glucose with the GEMSAEC (ENI) centrifugal analyzer by the glucose dehydrogenase reaction, and comparison with two commonly used procedures. , 1975, Clinical chemistry.
[63] D. Nebert,et al. Genetic expression of aryl hydrocarbon hydroxylase activity in the mouse. Distinction between the "responsive" homozygote and heterozygote at the Ah locus. , 1975, Archives of Biochemistry and Biophysics.
[64] W. Richmond. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. , 1973, Clinical chemistry.
[65] Gordon K. Smyth,et al. limma: Linear Models for Microarray Data , 2005 .
[66] W. Watson,et al. Albumin standards and the measurement of serum albumin with bromcresol green. 1971. , 1997, Clinica chimica acta; international journal of clinical chemistry.
[67] A Poland,et al. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. , 1982, Annual review of pharmacology and toxicology.
[68] A. Karmen,et al. Transaminase activity in human blood. , 1955, The Journal of clinical investigation.
[69] Karl H. Van Norman. The Biuret Reaction and the Cold Nitric Acid Test in the Recognition of Protein. , 1909 .